Cargando…
IL-1β-Mediated Activation of Adipose-Derived Mesenchymal Stromal Cells Results in PMN Reallocation and Enhanced Phagocytosis: A Possible Mechanism for the Reduction of Osteoarthritis Pathology
Background: Injection of adipose-derived mesenchymal stromal cells (ASCs) into murine knee joints after induction of inflammatory collagenase-induced osteoarthritis (CiOA) reduces development of joint pathology. This protection is only achieved when ASCs are applied in early CiOA, which is character...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545928/ https://www.ncbi.nlm.nih.gov/pubmed/31191517 http://dx.doi.org/10.3389/fimmu.2019.01075 |
_version_ | 1783423465405022208 |
---|---|
author | van Dalen, Stephanie C. M. Blom, Arjen B. Walgreen, Birgitte Slöetjes, Annet W. Helsen, Monique M. A. Geven, Edwin J. W. ter Huurne, Menno Vogl, Thomas Roth, Johannes van de Loo, Fons A. J. Koenders, Marije I. Casteilla, Louis van der Kraan, Peter M. van den Bosch, Martijn H. J. van Lent, Peter L. E. M. |
author_facet | van Dalen, Stephanie C. M. Blom, Arjen B. Walgreen, Birgitte Slöetjes, Annet W. Helsen, Monique M. A. Geven, Edwin J. W. ter Huurne, Menno Vogl, Thomas Roth, Johannes van de Loo, Fons A. J. Koenders, Marije I. Casteilla, Louis van der Kraan, Peter M. van den Bosch, Martijn H. J. van Lent, Peter L. E. M. |
author_sort | van Dalen, Stephanie C. M. |
collection | PubMed |
description | Background: Injection of adipose-derived mesenchymal stromal cells (ASCs) into murine knee joints after induction of inflammatory collagenase-induced osteoarthritis (CiOA) reduces development of joint pathology. This protection is only achieved when ASCs are applied in early CiOA, which is characterized by synovitis and high S100A8/A9 and IL-1β levels, suggesting that inflammation is a prerequisite for the protective effect of ASCs. Our objective was to gain more insight into the interplay between synovitis and ASC-mediated amelioration of CiOA pathology. Methods: CiOA was induced by intra-articular collagenase injection. Knee joint sections were stained with hematoxylin/eosin and immunolocalization of polymorphonuclear cells (PMNs) and ASCs was performed using antibodies for NIMP-R14 and CD271, respectively. Chemokine expression induced by IL-1β or S100A8/A9 was assessed with qPCR and Luminex. ASC-PMN co-cultures were analyzed microscopically and with Luminex for inflammatory mediators. Migration of PMNs through transwell membranes toward conditioned medium of non-stimulated ASCs (ASC(NS)-CM) or IL-1β-stimulated ASCs (ASC(IL-1β)-CM) was examined using flow cytometry. Phagocytic capacity of PMNs was measured with labeled zymosan particles. Results: Intra-articular saline injection on day 7 of CiOA increased synovitis after 6 h, characterized by PMNs scattered throughout the joint cavity and the synovium. ASC injection resulted in comparable numbers of PMNs which clustered around ASCs in close interaction with the synovial lining. IL-1β-stimulation of ASCs in vitro strongly increased expression of PMN-attracting chemokines CXCL5, CXCL7, and KC, whereas S100A8/A9-stimulation did not. In agreement, the number of clustered PMNs per ASC was significantly increased after 6 h of co-culturing with IL-1β-stimulated ASCs. Also migration of PMNs toward ASC(IL-1β)-CM was significantly enhanced (287%) when compared to ASC(NS)-CM. Interestingly, association of PMNs with ASCs significantly diminished KC protein release by ASCs (69% lower after 24 h), accompanied by reduced release of S100A8/A9 protein by the PMNs. Moreover, phagocytic capacity of PMNs was strongly enhanced after priming with ASC(IL-1β)-CM. Conclusions: Local application of ASCs in inflamed CiOA knee joints results in clustering of attracted PMNs with ASCs in the synovium, which is likely mediated by IL-1β-induced up-regulation of chemokine release by ASCs. This results in enhanced phagocytic capacity of PMNs, enabling the clearance of debris to attenuate synovitis. |
format | Online Article Text |
id | pubmed-6545928 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-65459282019-06-12 IL-1β-Mediated Activation of Adipose-Derived Mesenchymal Stromal Cells Results in PMN Reallocation and Enhanced Phagocytosis: A Possible Mechanism for the Reduction of Osteoarthritis Pathology van Dalen, Stephanie C. M. Blom, Arjen B. Walgreen, Birgitte Slöetjes, Annet W. Helsen, Monique M. A. Geven, Edwin J. W. ter Huurne, Menno Vogl, Thomas Roth, Johannes van de Loo, Fons A. J. Koenders, Marije I. Casteilla, Louis van der Kraan, Peter M. van den Bosch, Martijn H. J. van Lent, Peter L. E. M. Front Immunol Immunology Background: Injection of adipose-derived mesenchymal stromal cells (ASCs) into murine knee joints after induction of inflammatory collagenase-induced osteoarthritis (CiOA) reduces development of joint pathology. This protection is only achieved when ASCs are applied in early CiOA, which is characterized by synovitis and high S100A8/A9 and IL-1β levels, suggesting that inflammation is a prerequisite for the protective effect of ASCs. Our objective was to gain more insight into the interplay between synovitis and ASC-mediated amelioration of CiOA pathology. Methods: CiOA was induced by intra-articular collagenase injection. Knee joint sections were stained with hematoxylin/eosin and immunolocalization of polymorphonuclear cells (PMNs) and ASCs was performed using antibodies for NIMP-R14 and CD271, respectively. Chemokine expression induced by IL-1β or S100A8/A9 was assessed with qPCR and Luminex. ASC-PMN co-cultures were analyzed microscopically and with Luminex for inflammatory mediators. Migration of PMNs through transwell membranes toward conditioned medium of non-stimulated ASCs (ASC(NS)-CM) or IL-1β-stimulated ASCs (ASC(IL-1β)-CM) was examined using flow cytometry. Phagocytic capacity of PMNs was measured with labeled zymosan particles. Results: Intra-articular saline injection on day 7 of CiOA increased synovitis after 6 h, characterized by PMNs scattered throughout the joint cavity and the synovium. ASC injection resulted in comparable numbers of PMNs which clustered around ASCs in close interaction with the synovial lining. IL-1β-stimulation of ASCs in vitro strongly increased expression of PMN-attracting chemokines CXCL5, CXCL7, and KC, whereas S100A8/A9-stimulation did not. In agreement, the number of clustered PMNs per ASC was significantly increased after 6 h of co-culturing with IL-1β-stimulated ASCs. Also migration of PMNs toward ASC(IL-1β)-CM was significantly enhanced (287%) when compared to ASC(NS)-CM. Interestingly, association of PMNs with ASCs significantly diminished KC protein release by ASCs (69% lower after 24 h), accompanied by reduced release of S100A8/A9 protein by the PMNs. Moreover, phagocytic capacity of PMNs was strongly enhanced after priming with ASC(IL-1β)-CM. Conclusions: Local application of ASCs in inflamed CiOA knee joints results in clustering of attracted PMNs with ASCs in the synovium, which is likely mediated by IL-1β-induced up-regulation of chemokine release by ASCs. This results in enhanced phagocytic capacity of PMNs, enabling the clearance of debris to attenuate synovitis. Frontiers Media S.A. 2019-05-27 /pmc/articles/PMC6545928/ /pubmed/31191517 http://dx.doi.org/10.3389/fimmu.2019.01075 Text en Copyright © 2019 van Dalen, Blom, Walgreen, Slöetjes, Helsen, Geven, ter Huurne, Vogl, Roth, van de Loo, Koenders, Casteilla, van der Kraan, van den Bosch and van Lent. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology van Dalen, Stephanie C. M. Blom, Arjen B. Walgreen, Birgitte Slöetjes, Annet W. Helsen, Monique M. A. Geven, Edwin J. W. ter Huurne, Menno Vogl, Thomas Roth, Johannes van de Loo, Fons A. J. Koenders, Marije I. Casteilla, Louis van der Kraan, Peter M. van den Bosch, Martijn H. J. van Lent, Peter L. E. M. IL-1β-Mediated Activation of Adipose-Derived Mesenchymal Stromal Cells Results in PMN Reallocation and Enhanced Phagocytosis: A Possible Mechanism for the Reduction of Osteoarthritis Pathology |
title | IL-1β-Mediated Activation of Adipose-Derived Mesenchymal Stromal Cells Results in PMN Reallocation and Enhanced Phagocytosis: A Possible Mechanism for the Reduction of Osteoarthritis Pathology |
title_full | IL-1β-Mediated Activation of Adipose-Derived Mesenchymal Stromal Cells Results in PMN Reallocation and Enhanced Phagocytosis: A Possible Mechanism for the Reduction of Osteoarthritis Pathology |
title_fullStr | IL-1β-Mediated Activation of Adipose-Derived Mesenchymal Stromal Cells Results in PMN Reallocation and Enhanced Phagocytosis: A Possible Mechanism for the Reduction of Osteoarthritis Pathology |
title_full_unstemmed | IL-1β-Mediated Activation of Adipose-Derived Mesenchymal Stromal Cells Results in PMN Reallocation and Enhanced Phagocytosis: A Possible Mechanism for the Reduction of Osteoarthritis Pathology |
title_short | IL-1β-Mediated Activation of Adipose-Derived Mesenchymal Stromal Cells Results in PMN Reallocation and Enhanced Phagocytosis: A Possible Mechanism for the Reduction of Osteoarthritis Pathology |
title_sort | il-1β-mediated activation of adipose-derived mesenchymal stromal cells results in pmn reallocation and enhanced phagocytosis: a possible mechanism for the reduction of osteoarthritis pathology |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545928/ https://www.ncbi.nlm.nih.gov/pubmed/31191517 http://dx.doi.org/10.3389/fimmu.2019.01075 |
work_keys_str_mv | AT vandalenstephaniecm il1bmediatedactivationofadiposederivedmesenchymalstromalcellsresultsinpmnreallocationandenhancedphagocytosisapossiblemechanismforthereductionofosteoarthritispathology AT blomarjenb il1bmediatedactivationofadiposederivedmesenchymalstromalcellsresultsinpmnreallocationandenhancedphagocytosisapossiblemechanismforthereductionofosteoarthritispathology AT walgreenbirgitte il1bmediatedactivationofadiposederivedmesenchymalstromalcellsresultsinpmnreallocationandenhancedphagocytosisapossiblemechanismforthereductionofosteoarthritispathology AT sloetjesannetw il1bmediatedactivationofadiposederivedmesenchymalstromalcellsresultsinpmnreallocationandenhancedphagocytosisapossiblemechanismforthereductionofosteoarthritispathology AT helsenmoniquema il1bmediatedactivationofadiposederivedmesenchymalstromalcellsresultsinpmnreallocationandenhancedphagocytosisapossiblemechanismforthereductionofosteoarthritispathology AT gevenedwinjw il1bmediatedactivationofadiposederivedmesenchymalstromalcellsresultsinpmnreallocationandenhancedphagocytosisapossiblemechanismforthereductionofosteoarthritispathology AT terhuurnemenno il1bmediatedactivationofadiposederivedmesenchymalstromalcellsresultsinpmnreallocationandenhancedphagocytosisapossiblemechanismforthereductionofosteoarthritispathology AT voglthomas il1bmediatedactivationofadiposederivedmesenchymalstromalcellsresultsinpmnreallocationandenhancedphagocytosisapossiblemechanismforthereductionofosteoarthritispathology AT rothjohannes il1bmediatedactivationofadiposederivedmesenchymalstromalcellsresultsinpmnreallocationandenhancedphagocytosisapossiblemechanismforthereductionofosteoarthritispathology AT vandeloofonsaj il1bmediatedactivationofadiposederivedmesenchymalstromalcellsresultsinpmnreallocationandenhancedphagocytosisapossiblemechanismforthereductionofosteoarthritispathology AT koendersmarijei il1bmediatedactivationofadiposederivedmesenchymalstromalcellsresultsinpmnreallocationandenhancedphagocytosisapossiblemechanismforthereductionofosteoarthritispathology AT casteillalouis il1bmediatedactivationofadiposederivedmesenchymalstromalcellsresultsinpmnreallocationandenhancedphagocytosisapossiblemechanismforthereductionofosteoarthritispathology AT vanderkraanpeterm il1bmediatedactivationofadiposederivedmesenchymalstromalcellsresultsinpmnreallocationandenhancedphagocytosisapossiblemechanismforthereductionofosteoarthritispathology AT vandenboschmartijnhj il1bmediatedactivationofadiposederivedmesenchymalstromalcellsresultsinpmnreallocationandenhancedphagocytosisapossiblemechanismforthereductionofosteoarthritispathology AT vanlentpeterlem il1bmediatedactivationofadiposederivedmesenchymalstromalcellsresultsinpmnreallocationandenhancedphagocytosisapossiblemechanismforthereductionofosteoarthritispathology |